Danaher Corporation (DHR) Financials
Key financial figures for Danaher Corporation (Q2 2026).
Danaher Q2 2026 revenue rose 5.5% YoY to $6.265 billion as core revenue growth reaccelerated to 3.0% from 0.5% in Q1, and adjusted diluted EPS grew 8.0% to $1.94. Revenue of $6.265 billion, up 5.5% YoY (3.0% core, 4.5% ex-respiratory testing); net earnings $870 million, or $1.23 diluted EPS, up 60% YoY against an easy comp Adjusted diluted EPS of $1.94, up 8.0% YoY; operating cash flow $1.534 billion and non-GAAP free cash flow $1.265 billion, up 15.5% YoY All three segments grew: Diagnostics +7.0% total (+2.0% core), Life Sciences +5.5% total (+5.5% core, strongest in several years per management), Biotechnology +4.0% total (+2.5% core) Bioprocessing orders grew mid-teens YoY even as reported bioprocessing revenue lagged on customer project timing, per. On the outlook: FY2026 non-GAAP core revenue growth of 3.0%-4.0% and adjusted diluted EPS of $8.45-$8.60 (raised from $8.35-$8.55); Q3 2026 core revenue growth guided to 2.0%-3.0%. Figures are for Q2 2026, as Danaher Corporation reported them.
- Revenue
- $6.3B
- Net Income
- $870M
- EPS
- $1.23
- Total Assets
- $92.4B
- Operating Cash Flow
- $1.5B
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $6.3B | $870M | $1.23 | 17.99% | $1.3B |
| Q1 FY2026 | $6.0B | $1.0B | $1.45 | 22.58% | $1.1B |
| Q4 FY2025 | $6.8B | $1.2B | $1.68 | 21.97% | $1.7B |
| Q3 FY2025 | $6.1B | $908M | $1.27 | 19.06% | $1.4B |
| Q2 FY2025 | $5.9B | $555M | $0.77 | 20.08% | $1.1B |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $24.6B | $3.6B | $5.04 | 20.91% | $5.3B |
| FY2024 | $23.9B | $3.9B | $5.29 | 21.71% | $5.3B |
| FY2023 | $23.9B | $4.8B | $6.38 | 22.1% | $5.8B |
Frequently asked questions
What was Danaher Corporation's revenue last quarter?
Danaher Corporation reported revenue of $6.27 billion for Q2 FY2026, up 5.5% from the same period a year earlier.
Is Danaher Corporation profitable?
Yes. Danaher Corporation reported net income of $870.0 million for Q2 FY2026, a net margin of 13.89% on revenue.
How has Danaher Corporation's margin trended?
Operating margin was 17.99% in Q2 FY2026, compared with 20.08% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
When does Danaher Corporation report next?
Danaher Corporation is scheduled to report results on 2026-10-20. The company has confirmed that date.
Full income statement, balance sheet and cash flow for Danaher Corporation on SentiSense, with up to forty quarters and twenty fiscal years of history.